Pyruvate is made in the cytosol, the fluid-filled space outside the nucleus and organelles of the cell. It’s the end product of glycolysis, a 10-step process that breaks glucose in half. Each glucose molecule yields two molecules of pyruvate, and the entire sequence happens in this watery compartment before pyruvate moves elsewhere for further processing.
How Glycolysis Produces Pyruvate
Glycolysis splits one six-carbon glucose molecule into two three-carbon pyruvate molecules through a chain of enzyme-driven reactions, all taking place in the cytosol. The pathway has two phases: an early investment phase that uses two ATP molecules to energize the glucose, and a later payoff phase that generates four ATP and two molecules of NADH (an electron carrier your cells use to produce more energy later). The net gain is two ATP and two NADH per glucose.
The final step is the one that actually creates pyruvate. An enzyme called pyruvate kinase converts a precursor molecule (phosphoenolpyruvate, or PEP) into pyruvate while simultaneously generating one ATP. Because two PEP molecules are produced from each glucose, this last step fires twice per glucose molecule. Pyruvate kinase is tightly regulated. An intermediate from earlier in glycolysis (fructose 1,6-bisphosphate) acts as an accelerator, ramping up the enzyme’s activity when glycolysis is running fast. In muscle and brain tissue, the amino acid phenylalanine acts as a brake, slowing the enzyme down.
Other Ways the Cell Makes Pyruvate
Glycolysis is the primary source, but it isn’t the only one. Several amino acids, including alanine, serine, glycine, and cysteine, can be converted into pyruvate. The most direct route is from alanine: an enzyme called alanine aminotransferase swaps alanine’s nitrogen-containing group onto another molecule, leaving behind pyruvate. This reaction is reversible and happens in the cytosol as well, connecting protein metabolism to the same energy pathways that process sugar.
Lactate can also be converted back into pyruvate. During intense exercise, muscles produce lactate faster than the blood can clear it. That lactate travels to the liver, where an enzyme (lactate dehydrogenase) runs the reaction in reverse, regenerating pyruvate. The heart does something similar: cardiac muscle preferentially converts circulating lactate into pyruvate and burns it for fuel. Different versions of lactate dehydrogenase exist in different tissues, and the version found in heart muscle has a stronger preference for pulling lactate back toward pyruvate.
What Happens to Pyruvate After It’s Made
Once pyruvate exists in the cytosol, it faces a fork in the road. When oxygen is available, most pyruvate enters the mitochondria for a much larger energy payoff. Getting there requires a dedicated gateway: the mitochondrial pyruvate carrier (MPC), a protein complex made of two subunits called MPC1 and MPC2. Discovered in 2012, this carrier sits in the inner mitochondrial membrane and controls how much pyruvate flows into the organelle. It’s a critical bottleneck for the cell’s energy supply.
Inside the mitochondria, pyruvate can take one of two main paths. It can be stripped of a carbon atom and converted into acetyl-CoA, which feeds into the citric acid cycle to generate large amounts of ATP. Alternatively, an enzyme called pyruvate carboxylase can attach a carbon dioxide molecule to pyruvate, turning it into oxaloacetate. This reaction, which requires the vitamin biotin, is the first step of gluconeogenesis, the process by which your liver builds new glucose molecules when blood sugar runs low. Oxaloacetate also supports the synthesis of amino acids, fats, and nucleotides, making pyruvate a versatile building block beyond its role in energy production.
When oxygen is scarce, as in sprinting muscles, pyruvate stays in the cytosol and is converted into lactate instead. This allows glycolysis to keep running by recycling the NADH that would otherwise accumulate and stall the pathway.
Why the Location Matters
The fact that pyruvate is made in the cytosol and must be actively transported into mitochondria has real biological consequences. Red blood cells, for example, have no mitochondria at all. They depend entirely on glycolysis for energy, which means pyruvate kinase is their rate-limiting enzyme for ATP production. People born with mutations that cripple pyruvate kinase develop a condition called pyruvate kinase deficiency. Their red blood cells can’t produce enough ATP to maintain their membranes, so the cells become rigid, break down prematurely in the spleen, and cause chronic anemia.
The spatial separation also gives cells a layer of control. By regulating how much pyruvate the mitochondrial carrier lets in, a cell can shift its metabolism between burning fuel for energy and diverting carbon toward building new molecules. Cancer cells, for instance, often downregulate the mitochondrial pyruvate carrier, keeping more pyruvate in the cytosol where it can be rerouted into the raw materials needed for rapid growth. The simple geography of where pyruvate is made versus where it’s consumed turns out to be one of the cell’s most important metabolic switches.